FEB 22, 2017 10:30 AM PST

NGS live in your lab in 30 days

Speakers

Abstract

Identification of the many complex genetic aberrations associated with cancers, and deciphering their role in disease progression and response to treatment is one of the major challenges faced by oncology researchers.   Next-Generation Sequencing has the potential to provide unprecedented insight into the complex molecular pathology of diseases such as cancer. However, broad adoption of NGS technology by small and medium sized laboratories can be daunting due to the inherent complexity of the technology, workflow fragmentation and cost obscurity, all of which lead to protracted investment of time and resources.

 

The QIAGEN GeneReader NGS System was developed specifically with small to medium throughput laboratories in mind. The system is the world’s first truly Sample to Insight NGS workflow integrating all upstream sample processing steps, as well as downstream bioinformatics analysis and interpretation. It has the added benefit of the standardization offered by a single vendor workflow solution, and scalability options to fit laboratories individual throughput needs.  This is an all-in-one solution that enables any research lab to chart the complex cancer genetic map while also providing up-to-date information, curated in the QIAGEN world leading Knowledge base that can be used to guide result interpretation.

 

In today’s webinar, Salim Essakali will highlight the benefits of a complete NGS system that can lead you from nucleic acid extraction, through sequencing template preparation and sequencing to analysis and interpretation of the data generated. 

 

In the second part, Dr. Yi Kong will introduce the new QIAGEN program ‘NGS live in your lab in 30 days’.  She will also share some of the experiences and data generated by early adopters of the GeneReader NGS System from around the globe.  

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
FEB 22, 2017 10:30 AM PST

NGS live in your lab in 30 days


Specialty

Biotechnology

Tumor

Drug Discovery

Cancer Research

Cancer

Clinical Diagnostics

University

Virology

Cancer Treatment

Immunology

Dna Sequencing

Molecular Biology

Cancer Diagnostics

Mass Cytometry

Antibodies

Geography

North America33%

Asia33%

Europe33%

Registration Source

Website Visitors100%

Job Title

Student33%

Medical Laboratory Technician33%

Lab Management33%

Organization

Independent Laboratories33%

Manufacturer - Other33%

Academic Institution33%


Show Resources
Loading Comments...
Show Resources